applied a cholesterol-conjugated TLR7 agonist liposome in combination with radiotherapy in a mouse model, demonstrating that this combined strategy significantly inhibited tumor growth and induced anti-tumor immune responses (209). The gene discussed is TLR7; the disease is neoplasm.